The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 10, 2022

Filed:

Nov. 26, 2019
Applicant:

Mallinckrodt Pharmaceuticals Ireland Limited, Dublin, IE;

Inventors:

Jaron Acker, Madison, WI (US);

Muhammad Asif, New Fairfield, CT (US);

Craig Flanagan, Belmar, NJ (US);

Douglas Alan Greene, Basking Ridge, NJ (US);

Sarah Jayne Ridley, Philipsburg, NJ (US);

Frank Kenneth Schweighardt, Allentown, PA (US);

Lien-Lung Sheu, Berkeley Heights, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 16/12 (2006.01); C01B 21/24 (2006.01); B01D 53/04 (2006.01); A61M 16/06 (2006.01); A61M 16/00 (2006.01); A61M 16/10 (2006.01); A61M 16/16 (2006.01); A61M 16/20 (2006.01);
U.S. Cl.
CPC ...
A61M 16/12 (2013.01); A61M 16/0051 (2013.01); A61M 16/024 (2017.08); A61M 16/06 (2013.01); A61M 16/10 (2013.01); B01D 53/0415 (2013.01); C01B 21/24 (2013.01); A61M 16/0063 (2014.02); A61M 16/16 (2013.01); A61M 16/161 (2014.02); A61M 16/202 (2014.02); A61M 2016/003 (2013.01); A61M 2016/1035 (2013.01); A61M 2202/0275 (2013.01); A61M 2205/12 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3317 (2013.01); A61M 2205/3324 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/583 (2013.01); A61M 2205/584 (2013.01); A61M 2205/707 (2013.01); B01D 53/0446 (2013.01); B01D 2253/106 (2013.01); B01D 2257/404 (2013.01); B01D 2259/4533 (2013.01);
Abstract

The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NOto NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO2-to-NO reactor cartridge and/or a break-through of NO, and providing an indication of the remaining useful life and/or break-through.


Find Patent Forward Citations

Loading…